Key Real-World Indicators Predict Muscarinic Response in Psychosis
In a groundbreaking advance for psychiatric therapeutics, the recent FDA approval of xanomeline/trospium combination—marketed as Cobenfy—marks a pivotal moment in ...
In a groundbreaking advance for psychiatric therapeutics, the recent FDA approval of xanomeline/trospium combination—marketed as Cobenfy—marks a pivotal moment in ...
A groundbreaking study spearheaded by researchers at NYU Langone Health unveils critical brain circuits that enhance the stability of memories ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine